These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 31360627

  • 1. Acylated Ghrelin Renders Chemosensitive Ovarian Cancer Cells Resistant to Cisplatin Chemotherapy via Activation of the PI3K/Akt/mTOR Survival Pathway.
    El-Kott AF, Shati AA, Al-Kahtani MA, Alqahtani S.
    Anal Cell Pathol (Amst); 2019; 2019():9627810. PubMed ID: 31360627
    [Abstract] [Full Text] [Related]

  • 2. Ghrelin induces colon cancer cell proliferation through the GHS-R, Ras, PI3K, Akt, and mTOR signaling pathways.
    Lien GS, Lin CH, Yang YL, Wu MS, Chen BC.
    Eur J Pharmacol; 2016 Apr 05; 776():124-31. PubMed ID: 26879868
    [Abstract] [Full Text] [Related]

  • 3. Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells In Vitro and In Vivo through Inhibiting the PI3K/AKT/mTOR/NF-κB Signaling Pathway.
    Yang H, Li H, Lu S, Shan S, Guo Y.
    Biomed Res Int; 2022 Apr 05; 2022():5739909. PubMed ID: 35281608
    [Abstract] [Full Text] [Related]

  • 4. Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells.
    Chung H, Seo S, Moon M, Park S.
    J Endocrinol; 2008 Sep 05; 198(3):511-21. PubMed ID: 18541646
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J, Bai X, Feng X, Ni J, Beretov J, Graham P, Li Y.
    BMC Cancer; 2019 Jun 24; 19(1):618. PubMed ID: 31234823
    [Abstract] [Full Text] [Related]

  • 6. Polypeptide LTX-315 reverses the cisplatin chemoresistance of ovarian cancer cells via regulating Beclin-1/PI3K/mTOR signaling pathway.
    Ma J, Liu L, Ling Y, Zheng J.
    J Biochem Mol Toxicol; 2021 Sep 24; 35(9):e22853. PubMed ID: 34309113
    [Abstract] [Full Text] [Related]

  • 7. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.
    Liu M, Qi Z, Liu B, Ren Y, Li H, Yang G, Zhang Q.
    Oncotarget; 2015 Sep 22; 6(28):25281-94. PubMed ID: 26325371
    [Abstract] [Full Text] [Related]

  • 8. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
    Zhang S, Leng T, Zhang Q, Zhao Q, Nie X, Yang L.
    Biomed Pharmacother; 2018 Jun 22; 102():302-308. PubMed ID: 29571014
    [Abstract] [Full Text] [Related]

  • 9. The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways.
    Favaro E, Granata R, Miceli I, Baragli A, Settanni F, Cavallo Perin P, Ghigo E, Camussi G, Zanone MM.
    Diabetologia; 2012 Apr 22; 55(4):1058-70. PubMed ID: 22231124
    [Abstract] [Full Text] [Related]

  • 10. The proliferative effects of ghrelin on human gastric cancer AGS cells.
    Tian PY, Fan XM.
    J Dig Dis; 2012 Sep 22; 13(9):453-8. PubMed ID: 22908970
    [Abstract] [Full Text] [Related]

  • 11. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
    Liu M, Bamodu OA, Huang WC, Zucha MA, Lin YK, Wu ATH, Huang CC, Lee WH, Yuan CC, Hsiao M, Deng L, Tzeng YM, Yeh CT.
    Toxicol Appl Pharmacol; 2017 Jun 15; 325():48-60. PubMed ID: 28408137
    [Abstract] [Full Text] [Related]

  • 12. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y, Chen X, Luo Z.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun 15; 30(6):592-6. PubMed ID: 24909280
    [Abstract] [Full Text] [Related]

  • 13. Endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance in human ovarian cancer cells.
    Hu JL, Hu XL, Guo AY, Wang CJ, Wen YY, Cang SD.
    Oncotarget; 2017 Jul 25; 8(30):49380-49394. PubMed ID: 28537902
    [Abstract] [Full Text] [Related]

  • 14. TDRG1 regulates chemosensitivity of seminoma TCam-2 cells to cisplatin via PI3K/Akt/mTOR signaling pathway and mitochondria-mediated apoptotic pathway.
    Gan Y, Wang Y, Tan Z, Zhou J, Kitazawa R, Jiang X, Tang Y, Yang J.
    Cancer Biol Ther; 2016 Jul 02; 17(7):741-50. PubMed ID: 27104982
    [Abstract] [Full Text] [Related]

  • 15. [Effects of PI3K/Akt/NF-κB signal pathway on FSH facilitation on cell proliferation and invasion by human epithelial ovarian cancer].
    Xu CL, Lu XL, Yan XN, Wang HL, Chen SQ.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb 02; 47(2):134-8. PubMed ID: 22455747
    [Abstract] [Full Text] [Related]

  • 16. Ghrelin stimulates angiogenesis via GHSR1a-dependent MEK/ERK and PI3K/Akt signal pathways in rat cardiac microvascular endothelial cells.
    Wang L, Chen Q, Li G, Ke D.
    Peptides; 2012 Jan 02; 33(1):92-100. PubMed ID: 22100225
    [Abstract] [Full Text] [Related]

  • 17. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S, Gonugunta VK, Penugurti V, Malisetty VL, Vadlamudi RK, Manavathi B.
    Cell Oncol (Dordr); 2017 Apr 02; 40(2):133-144. PubMed ID: 28039608
    [Abstract] [Full Text] [Related]

  • 18. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling.
    Granata R, Settanni F, Biancone L, Trovato L, Nano R, Bertuzzi F, Destefanis S, Annunziata M, Martinetti M, Catapano F, Ghè C, Isgaard J, Papotti M, Ghigo E, Muccioli G.
    Endocrinology; 2007 Feb 02; 148(2):512-29. PubMed ID: 17068144
    [Abstract] [Full Text] [Related]

  • 19. Label-free-based quantitative proteomic analysis of the inhibition of cisplatin-resistant ovarian cancer cell proliferation by cucurbitacin B.
    Yin S, Mai Z, Liu C, Xu L, Xia C.
    Phytomedicine; 2023 Mar 02; 111():154669. PubMed ID: 36681055
    [Abstract] [Full Text] [Related]

  • 20. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
    Asselin E, Mills GB, Tsang BK.
    Cancer Res; 2001 Mar 01; 61(5):1862-8. PubMed ID: 11280739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.